1)  Systemic inflammation
全身炎症
2)  systemic inflammatory response syndrome
全身炎症反应
1.
Therapeutic effect of reduced glutathione on systemic inflammatory response syndrome with severe trauma;
还原型谷胱甘肽治疗重度创伤后全身炎症反应综合征观察
2.
Objective To explore the change of plasma procalcitonin level and the relation between procalcitonin and cytokines by testing the procalcitonin during the cardiopulmonary bypass operation in infants and evaluate whether the procalcitonin can affect the severity of the systemic inflammatory response syndrome and its diagnostic value for bacterial infections.
目的通过对小婴儿体外循环围术期降钙素原值的测定,了解其变化规律及其和炎症因子变化的相关性,评价降钙素原是否能反映全身炎症反应的严重程度及围术期细菌感染的诊断价值。
3.
Objective: To evaluate the incidence of systemic inflammatory response syndrome (SIRS) and single/multiple organ dysfunction syndrome (S/MODS) in patients who underwent aneurysmectomy.
目的 :观察腹主动脉瘤患者手术后全身炎症反应 (SIRS)及单个 /多器官功能障碍 (S/MODS)发生率。
3)  systemic inflammatory response
全身炎症反应
1.
Objective: Investigate whether Ulinastalin can reduce the systemic inflammatory response which induced by cardiopulmonary bypass.
结论乌司他丁可明显减少CPB术后TNF-a,IL-6和IL-8的释放,可减轻CPB术后全身炎症反应。
2.
OBJECTIVE Investigate whether fructose 1, 6-diphosphate (FDP) can reduce the systemic inflammatory response which induced by cardiopulmonary bypass.
目的　通过观察体外循环 (CPB)中预充 1,6—二磷酸果糖 (FDP)对CPB术后促炎性细胞因子释放的影响 ,探讨它减轻CPB术后全身炎症反应的作用和机理。
3.
To recognize the clinic significance of systemic inflammatory response syndrome(SIRS)and multiple organ dysfunction syndromes(MODS).
目的 :探讨小儿全身炎症反应综合征 (SIRS)和多器官功能不全综合征 (MODS)的临床意义。
4)  SIRS
全身炎症反应（SIRS）
5)  systemic inflammatory response syndrome (SIRS)
全身炎症反应综合征
1.
Correlation of Systemic Inflammatory Response Syndrome (SIRS) with Death of Cholangitis-originated Shock in the Aged;
全身炎症反应综合征与老年胆源性休克病人死亡的相关性调查
2.
Objective To observe the intervention of systemic inflammatory response syndrome (SIRS) at early stage in newborn infants with low-dose hepsrin.
目的观察小剂量肝素对危重新生儿全身炎症反应综合征(SIRS)的治疗效果及预后的影响。
6)  systemic inflammatory response syndrome(SIRS)
全身炎症反应综合征
1.
To study the protection of combination of Detoxication and Anti-inflammatory Mixture and Tienam on systemic inflammatory response syndrome(SIRS)of rat moeels.
目的:研究解毒抗炎合剂联合泰能对腹腔感染(CLP)所致大鼠全身炎症反应综合征(SIRS)的保护作用。
2.
Objective To explore changes and clinical significance of coagulation functions in children with systemic inflammatory response syndrome(SIRS).
目的探讨全身炎症反应综合征(SIRS)的危重病患儿凝血功能的变化及临床意义。
参考词条
补充资料：全身性炎症反应综合征


全身性炎症反应综合征


　　机体对各种严重损伤，包括感染、创伤、烧伤、缺氧和再灌注等引起的全身反应。它不是一种新发现的疾病，而是基于对感染、炎症和严重损伤发生、发展机制深入认识，原于20世纪90年代初由美国胸科医学会和危害急救医学会提出的新概念。这种反应有下列四种表现：体温升高或降低，心率和呼吸增快，白细胞增高或减少、分类左移。炎症介质失控性释放是其主要发生机制。其特征是全身的高代谢反应，表现为高通气量、高血糖、蛋白分解增加和高乳酸血症和体内炎症介质浓度增高。早期预防、诊断和治疗有利于降低小儿SIRS发病率和病死率。
　　
说明：补充资料仅用于学习参考，请勿用于其它任何用途。